Stocks
FibroGen (FGEN) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -333.7 | -282.8 | -305.2 | -142.4 | -45.9 | -45.5 | ||
| Changes by years, y/y, % | +103% | -15% | +8% | -53% | -68% | -22.5% | |||
FibroGen. EBITDA US GAAP, bln rub
FibroGen. EBITDA US GAAP, changes, %
FibroGen. EBITDA US GAAP, sum by quarters, bln rub
FibroGen (FGEN) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -14.2 | -11.5 | -10.9 | -9.30 | 0.007 | -45.5 | |
| Changes by years, y/y, % | -71% | -75% | -11% | -90% | -100% | |||
| Changes by quarters, q/q, % | -84% | -19% | -6% | -14% | -100% | |||
